GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innogene Co Ltd (XKRX:344860) » Definitions » Capex-to-Operating-Income

Innogene Co (XKRX:344860) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Innogene Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Innogene Co's Capital Expenditure for the three months ended in Dec. 2024 was ₩0.00 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩33.28 Mil.

Hence, Innogene Co's Capex-to-Operating-Income for the three months ended in Dec. 2024 was 0.00.


Innogene Co Capex-to-Operating-Income Historical Data

The historical data trend for Innogene Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innogene Co Capex-to-Operating-Income Chart

Innogene Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial 0.01 - 0.02 0.04 0.06

Innogene Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - - -

Competitive Comparison of Innogene Co's Capex-to-Operating-Income

For the Biotechnology subindustry, Innogene Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innogene Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innogene Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Innogene Co's Capex-to-Operating-Income falls into.


;
;

Innogene Co Capex-to-Operating-Income Calculation

Innogene Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-39.6) / 630.49
=0.06

Innogene Co's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 33.281
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innogene Co  (XKRX:344860) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Innogene Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Innogene Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Innogene Co Business Description

Traded in Other Exchanges
N/A
Address
No. 301, 28, Digital-ro 33-gil, Guro-gu, Seoul, KOR
Innogene Co Ltd is a bio-technology company. The company provides treatment solutions using stem cells and databases for hair loss, psoriasis, skin regeneration and hair follicle formation. Also, the company helps in hair loss diagnosis.

Innogene Co Headlines

No Headlines